Breaking News

SK bioscience Introduces New Global Partnership Model for Vaccines

Offers partnership model to transplant vaccine manufacturing facilities, technologies, and products to any countries in need.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

SK bioscience, a global vaccine and biotech company, introduced a new global partnership model ‘Preparing for Next Pandemic through Global Partnership’ at the Riyadh Global Medical Biotechnology Summit 2023.   Jaeyong Ahn, CEO of SK bioscience shared the successful development history of Korea’s first COVID-19 vaccine while emphasizing the importance of global cooperation in terms of global health security. Further, he suggested a global cooperation based on the SK bioscience...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters